Nichols & Pratt Advisers LLP Medtronic PLC Transaction History

Nichols & Pratt Advisers LLP

$1.5 Billion
Q3 2024

A detailed history of Nichols & Pratt Advisers LLP transactions in Medtronic PLC stock. As of the latest transaction made, Nichols & Pratt Advisers LLP holds 158,397 shares of MDT stock, worth $12.9 Million. This represents 0.95% of its overall portfolio holdings.

Number of Shares

158,397

Previous 165,287 4.17%

Holding current value

$12.9 Million

Previous $13 Million 9.62%

% of portfolio

0.95%

Previous 0.9%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$76.84 - $91.03 $529,427 - $627,196	-6,890 Reduced 4.17%	158,397 $14.3 Million
Q2 2024 Jul 25, 2024	BUY	$78.71 - $87.02 $1,967 - $2,175	25 Added 0.02%	165,287 $13 Million
Q1 2024 Apr 29, 2024	SELL	$82.84 - $88.09 $111,751 - $118,833	-1,349 Reduced 0.81%	165,262 $14.4 Million
Q4 2023 Feb 07, 2024	SELL	$69.43 - $83.43 $16,663 - $20,023	-240 Reduced 0.14%	166,611 $13.7 Million
Q3 2023 Nov 09, 2023	BUY	$78.22 - $90.4 $16,035 - $18,532	205 Added 0.12%	166,851 $13.1 Million
Q2 2023 Aug 02, 2023	BUY	$79.47 - $91.38 $1.74 Million - $2.01 Million	21,950 Added 15.17%	166,646 $14.7 Million
Q1 2023 May 03, 2023	BUY	$76.72 - $87.58 $645,982 - $737,423	8,420 Added 6.18%	144,696 $11.7 Million
Q4 2022 Feb 03, 2023	BUY	$76.18 - $87.74 $138,190 - $159,160	1,814 Added 1.35%	136,276 $10.6 Million
Q3 2022 Nov 01, 2022	BUY	$80.75 - $95.31 $10,497 - $12,390	130 Added 0.1%	134,462 $10.9 Million
Q2 2022 Aug 04, 2022	BUY	$87.4 - $113.09 $74,727 - $96,691	855 Added 0.64%	134,332 $12.1 Million
Q1 2022 May 10, 2022	BUY	$100.58 - $112.38 $218,761 - $244,426	2,175 Added 1.66%	133,477 $14.8 Million
Q4 2021 Feb 08, 2022	BUY	$99.53 - $127.75 $105,501 - $135,415	1,060 Added 0.81%	131,302 $13.6 Million
Q3 2021 Nov 01, 2021	BUY	$122.75 - $135.17 $30,687 - $33,792	250 Added 0.19%	130,242 $16.5 Million
Q2 2021 Aug 09, 2021	BUY	$118.19 - $131.5 $153,647 - $170,950	1,300 Added 1.01%	129,992 $16.1 Million
Q1 2021 May 11, 2021	BUY	$111.18 - $119.74 $124,521 - $134,108	1,120 Added 0.88%	128,692 $15.2 Million
Q4 2020 Feb 08, 2021	BUY	$100.57 - $117.14 $353,503 - $411,747	3,515 Added 2.83%	127,572 $14.9 Million
Q3 2020 Nov 10, 2020	BUY	$90.13 - $108.78 $752,315 - $907,986	8,347 Added 7.21%	124,057 $12.9 Million
Q2 2020 Aug 10, 2020	BUY	$84.11 - $103.33 $114,389 - $140,528	1,360 Added 1.19%	115,710 $10.6 Million
Q1 2020 Apr 24, 2020	BUY	$72.92 - $121.3 $151,309 - $251,697	2,075 Added 1.85%	114,350 $10.2 Million
Q4 2019 Feb 07, 2020	SELL	$104.49 - $114.54 $759,015 - $832,018	-7,264 Reduced 6.08%	112,275 $12.7 Million
Q3 2019 Nov 07, 2019	BUY	$98.02 - $111.18 $125,465 - $142,310	1,280 Added 1.08%	119,539 $13 Million
Q2 2019 Aug 05, 2019	BUY	$84.15 - $99.38 $349,811 - $413,122	4,157 Added 3.64%	118,259 $11.5 Million
Q1 2019 Apr 30, 2019	BUY	$82.45 - $93.79 $545,819 - $620,889	6,620 Added 6.16%	114,102 $10.4 Million
Q4 2018 Feb 08, 2019	SELL	$85.8 - $99.49 $76,362 - $88,546	-890 Reduced 0.82%	107,482 $9.71 Million
Q3 2018 Nov 05, 2018	BUY	$85.91 - $99.17 $155,583 - $179,596	1,811 Added 1.7%	108,372 $10.7 Million
Q2 2018 Jul 27, 2018	BUY	$77.48 - $87.83 $70,196 - $79,573	906 Added 0.86%	106,561 $9.12 Million
Q1 2018 May 11, 2018	BUY	$76.55 - $87.26 $446,669 - $509,162	5,835 Added 5.85%	105,655 $8.42 Million
Q4 2017 Feb 09, 2018	BUY	$76.93 - $83.5 $9,923 - $10,771	129 Added 0.13%	99,820 $8.09 Million
Q3 2017 Nov 08, 2017	BUY	$77.71 - $84.6 $280,921 - $305,829	3,615 Added 3.76%	99,691 $7.76 Million
Q2 2017 Aug 08, 2017	BUY	N/A	96,076	96,076 $8.53 Million

Others Institutions Holding MDT

# of Institutions

2,288

Shares Held

1.02B

Call Options Held

8.05M

Put Options Held

7.19M

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $108B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nichols & Pratt Advisers LLP , based on Form 13F filings with the SEC.

News

Stay updated on Nichols & Pratt Advisers LLP with notifications on news.

Account

Nichols & Pratt Advisers LLP Medtronic PLC Transaction History